AAUS guideline for acute uncomplicated pyelonephritis

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Patients with acute uncomplicated pyelonephritis may have impaired immune function, worsening infections.
• Emerging antibiotic-resistant bacteria, including quinolone-resistant Escherichia coli and Extended spectrum beta-lactamase (ESBL) producers (E. coli, Klebsiella pneumoniae), necessitate revised treatment strategies.
• The increasing prevalence of antimicrobial resistance (AMR) requires reconsideration of antibiotic usage.

Purpose of the Study:

• To present updated recommendations for the treatment of acute uncomplicated pyelonephritis.
• To incorporate recent trends in antibiotic resistance into clinical guidelines.
• To guide healthcare providers in managing infections caused by resistant bacterial strains.

Main Methods:

• Review and synthesis of current data on antibiotic resistance patterns.
• Analysis of emerging antimicrobial agents effective against resistant bacteria.
• Development of revised therapeutic recommendations based on evidence.

Main Results:

• Identification of specific resistant bacterial threats, such as quinolone-resistant E. coli and ESBL-producing E. coli and K. pneumoniae.
• Acknowledgement of geographical variations in the emergence and spread of resistant strains.
• Highlighting the availability of new antimicrobial agents, including beta-lactamase inhibitor combinations.

Conclusions:

• The Asian Association of UTI & STI (AAUS) has released a new guideline for acute uncomplicated pyelonephritis.
• The guideline incorporates updated antibiotic recommendations to combat rising antimicrobial resistance.
• Revised strategies are crucial for effective management of pyelonephritis in the era of AMR.